Key Points
UiPath (PATH) stock rises 3.6% to $10.64 on automation demand.
Company trades at 20.48 P/E with 83.2% gross margins.
Meyka AI rates PATH as B+ with $14.15 yearly target.
Earnings report scheduled for May 28 could drive next move.
UiPath Inc. (NYSE: PATH) climbed 3.6% to $10.64 in pre-market trading, signaling renewed investor interest in the automation software leader. The robotic process automation (RPA) platform provider has faced headwinds this year, with PATH stock down 35% year-to-date. However, recent institutional buying and strong fundamentals suggest the market may be reassessing the company’s value. Meyka AI’s analysis reveals mixed signals: while valuation metrics remain elevated, the company’s cash position and growth trajectory offer potential upside for long-term investors.
PATH Stock Price Movement and Technical Setup
UiPath shares opened at $10.11 and reached a day high of $10.85, with trading volume at 28.2 million shares versus the 30-day average of 32.6 million. The stock trades above its 50-day average of $10.87 and below its 200-day average of $12.99, indicating consolidation within a downtrend.
Technical indicators show mixed momentum. The Relative Strength Index (RSI) sits at 52.16, suggesting neutral conditions. The MACD remains slightly negative at -0.14, while the Awesome Oscillator at -0.49 reflects cautious sentiment. Bollinger Bands position PATH near the middle band at $10.45, with support at $9.68 and resistance at $11.22.
Financial Metrics and Valuation Analysis
UiPath trades at a P/E ratio of 20.48 with earnings per share of $0.52. The company’s market capitalization stands at $5.73 billion with 538 million shares outstanding. Price-to-sales ratio of 3.57 reflects premium valuation typical of software infrastructure companies.
Key profitability metrics show strength: gross profit margin of 83.2% demonstrates pricing power, while net profit margin of 17.5% indicates operational efficiency. Free cash flow per share reached $0.66, and the current ratio of 2.48 signals solid liquidity. However, the company carries minimal debt with a debt-to-equity ratio of just 3.4%, providing financial flexibility for growth investments.
Growth Drivers and Analyst Sentiment
UiPath reported 9.3% revenue growth and 18% net income growth in the latest fiscal year, demonstrating accelerating profitability. Earnings per share grew 18.75%, outpacing revenue expansion. The company’s R&D spending increased 14.6%, reflecting commitment to AI-powered automation innovation.
Analyst consensus remains cautiously optimistic with 2 buy ratings, 12 hold ratings, and 1 sell rating. Recent institutional buying by DNB Asset Management signals confidence in the automation sector. The company reports earnings on May 28, which could provide fresh catalysts for PATH stock movement.
Meyka AI Grade and Investment Outlook
Meyka AI rates PATH with a grade of B+, reflecting balanced risk-reward dynamics. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating suggests a buy opportunity for investors with medium-term horizons.
Meyka AI’s forecast model projects yearly price targets of $14.15, implying 32.8% upside from current levels. The company’s strong cash position of $2.75 per share and minimal debt provide downside protection. These grades are not guaranteed and we are not financial advisors. Track PATH on Meyka for real-time updates and analyst coverage changes.
Final Thoughts
UiPath Inc. (PATH) stock’s 3.6% pre-market gain reflects growing recognition of the company’s automation platform value amid enterprise digital transformation trends. While year-to-date declines have created valuation opportunities, investors should monitor the May 28 earnings report for guidance on revenue acceleration and margin expansion. The combination of strong fundamentals, institutional accumulation, and Meyka AI’s B+ rating suggests PATH stock warrants consideration for growth-oriented portfolios, though elevated valuation multiples require patience for full recovery toward the $14.15 price target.
FAQs
PATH stock climbed on renewed institutional interest in automation software and strong fundamentals. Recent buying by DNB Asset Management and upcoming May 28 earnings boosted sentiment.
UiPath trades at $10.64 with a P/E ratio of 20.48, a $5.73 billion market cap, and trades on NYSE under ticker PATH.
Analyst consensus is mixed: 2 buy, 12 hold, 1 sell. Meyka AI assigns a B+ grade with a $14.15 price target, suggesting 32.8% upside potential.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)